Messenger RNA vaccines and neutralizing anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with immunodeficiency

被引：0
|
作者：
Mungmunpuntipantip, Rujittika [1 ]
Wiwanitkit, Viroj [2 ]
机构：
[1] Private Acad Consultant Ctr, Bangkok, Thailand
[2] Dr DY Patil Univ, Dept Community Med, Pune, Maharashtra, India
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2021年 / 127卷 / 06期
关键词：
D O I：
10.1016/j.anai.2021.09.007
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：703 / 703
页数：1
相关论文
共 50 条
  • [1] Detection of neutralizing anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with common variable immunodeficiency after immunization with messenger RNA vaccines
    Romano, Ciro
    Esposito, Sergio
    Donnarumma, Giovanna
    Marrone, Aldo
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (04) : 499 - 501
  • [2] Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy
    Barnard, Dale L.
    Kumaki, Yohichi
    FUTURE VIROLOGY, 2011, 6 (05) : 615 - 631
  • [3] The Promise and Peril of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Monoclonal Antibodies
    Davis, Jennifer M.
    Li, Jonathan Z.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (07) : 1257 - 1259
  • [4] Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection
    Nie, YC
    Wang, GW
    Shi, XL
    Zhang, H
    Qiu, Y
    He, ZP
    Wang, W
    Lian, GW
    Yin, XL
    Du, LY
    Ren, LL
    Wang, JW
    He, X
    Li, TS
    Deng, HK
    Ding, MX
    JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (06): : 1119 - 1126
  • [5] Protection Against Severe Clinical Outcomes With Adenovirus or Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Patients Hospitalized With Coronavirus Disease 2019
    Llibre, Josep M.
    Revollo, Boris
    Aguilar, Sergi
    Calomarde-Gomez, Cristina
    Bruguera, Andreu
    Martin-Iguacel, Raquel
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (05): : 938 - 940
  • [6] Current development of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies (Review)
    Zhang, Tong
    Yang, Di
    Tang, Liang
    Hu, Yu
    MOLECULAR MEDICINE REPORTS, 2024, 30 (02)
  • [7] Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt
    El Rifay, Amira S.
    Mahmoud, Sara H.
    Marouf, Mohamed A.
    Gomaa, Mokhtar R.
    El Taweel, Ahmed
    Shama, Noura M. Abo
    GabAllah, Mohamed
    Dayem, Soha M. Abd El
    Kandeil, Ahmed
    Mostafa, Ahmed
    El-Shesheny, Rabeh
    Kayali, Ghazi
    Ali, Mohamed A.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2021, 15 (06) : 750 - 756
  • [8] Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2
    Grzelak, Ludivine
    Velay, Aurelie
    Madec, Yoann
    Gallais, Floriane
    Staropoli, Isabelle
    Schmidt-Mutter, Catherine
    Wendling, Marie-Josee
    Meyer, Nicolas
    Planchais, Cyril
    Rey, David
    Mouquet, Hugo
    Reix, Nathalie
    Glady, Ludovic
    Hansmann, Yves
    Bruel, Timothee
    De Seze, Jerome
    Fontanet, Arnaud
    Gonzalez, Maria
    Schwartz, Olivier
    Fafi-Kremer, Samira
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (06): : 983 - 988
  • [9] In vitro anti-severe acute respiratory syndrome coronavirus 2 effect of Ephedra przewalskii Stapf extract
    Kakimoto, Masaki
    Nomura, Toshihito
    Nazmul, Tanuza
    Yamamoto, Akima
    Sasaki, Hiroaki
    Higashiura, Akifumi
    Ito, Masanori
    Ohge, Hiroki
    Mikage, Masayuki
    Ogawa, Keiko Ochiai
    Sakaguchi, Takemasa
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 319
  • [10] Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States
    Tenforde, Mark W.
    Patel, Manish M.
    Ginde, Adit A.
    Douin, David J.
    Talbot, H. Keipp
    Casey, Jonathan D.
    Mohr, Nicholas M.
    Zepeski, Anne
    Gaglani, Manjusha
    McNeal, Tresa
    Ghamande, Shekhar
    Shapiro, Nathan, I
    Gibbs, Kevin W.
    Files, D. Clark
    Hager, David N.
    Shehu, Arber
    Prekker, Matthew E.
    Erickson, Heidi L.
    Exline, Matthew C.
    Gong, Michelle N.
    Mohamed, Amira
    Henning, Daniel J.
    Steingrub, Jay S.
    Peltan, Ithan D.
    Brown, Samuel M.
    Martin, Emily T.
    Monto, Arnold S.
    Khan, Akram
    Hough, Catherine L.
    Busse, Laurence W.
    ten Lohuis, Caitlin C.
    Duggal, Abhijit
    Wilson, Jennifer G.
    Gordon, Alexandra June
    Qadir, Nida
    Chang, Steven Y.
    Mallow, Christopher
    Gershengorn, Hayley B.
    Babcock, Hilary M.
    Kwon, Jennie H.
    Halasa, Natasha
    Chappell, James D.
    Lauring, Adam S.
    Grijalva, Carlos G.
    Rice, Todd W.
    Jones, Ian D.
    Stubblefield, William B.
    Baughman, Adrienne
    Womack, Kelsey N.
    Lindsell, Christopher J.
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (09) : 1515 - 1524
12345